HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Financing OTC Devices Business Strategies

OTC Digital Health Technology Companies Noom, Hello Heart Score Additional Funding

  • News

Executive Summary

Akili Interactive, Hello Heart and Noom announced new funding rounds today, proving that investors’ strong appetite for companies that are part of the digital transformation in health care.

You may also be interested in...



LifeScan Announces Partnership With Fitbit To Monitor Blood Glucose

The collaboration will provide a Fitbit smartwatch to users of LifeScan’s OneTouch Reveal blood glucose monitoring app.

Digital Health Roundup, April 2021: Digital Transformation In OR, Clinical Trials, Remote Monitoring

In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from April.

Conquering Metabesity: Expert Panel Discusses Roadmap To Find Solutions

Metabesity is a complex issue that will require a multi-disciplinary approach, concerted effort and clear regulatory pathway to achieve solutions.

Table

View full table

Related Content

Medtech Insight

Topics

Related Companies

Tags:
Financing OTC Devices Business Strategies
Latest Headlines

MacuHealth Asserts ‘Rigorous Process’ In Research Supporting Claims, But No Bill Of Health From NAD

Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement

FDA’s Linda Katz Takes MoCRA Questions At IBA Regulatory Workshop

Health And Wellness Weekly Trademarks Review: 19 September

See All
UsernamePublicRestriction

Register

RS151383

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By